Clay B. Siegall, President and CEO at Immunome Inc. (IMNM), bought 93,022 shares at $21.50 ($2.0M) on 2025-12-18, disclosed to the SEC on 2025-12-18.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $21.50 | 46,511 | $1000K | 50.0% |
| 2 | $21.50 | 46,511 | $1000K | 50.0% |
| Total | $21.50 avg | 93,022 | $2.0M | 100% |
| Filing → |
| IMNM | BUY | 2025-12-30 | $200K | — | Filing → |
| IMNM | BUY | 2025-12-22 | $298K | — | Filing → |
| IMNM | BUY | 2025-03-26 | $999K | — | Filing → |